Who owns the ONCOLYTIC IMMUNOTHERAPY trademark?

The ONCOLYTIC IMMUNOTHERAPY trademark is owned by CG Oncology, Inc..

What is the serial number for ONCOLYTIC IMMUNOTHERAPY?

The USPTO serial number for ONCOLYTIC IMMUNOTHERAPY is 98452032.

What is the registration number for ONCOLYTIC IMMUNOTHERAPY?

ONCOLYTIC IMMUNOTHERAPY is registered under USPTO registration number 0.

ONC

USPTO Trademark Record

ABANDONED

ONCOLYTIC IMMUNOTHERAPY

Q: What class is the ONCOLYTIC IMMUNOTHERAPY trademark registered in?

The ONCOLYTIC IMMUNOTHERAPY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 98452032·Reg 0·Filed Mar 15, 2024

Owner CG Oncology, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ONCOLYTIC IMMUNOTHERAPY (Serial No. 98452032), Registration No. 0, is a abandoned US trademark filed on Mar 15, 2024 by CG Oncology, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

ONCOLYTIC IMMUNOTHERAPY (Reg. #0) is an abandoned US trademark that was filed in 2024 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Mar 15, 2024

SERIAL

98452032

REG#

Owner

Applicant

CG Oncology, Inc.

Entity

Corporation

State

Address

400 Spectrum Center Dr., Suite 2040, Irvine, CA, 92618

Country

Attorney

NamePerry J. Viscounty

Law firm

Perry J. Viscounty Latham & Watkins LLP

Address

650 Town Center Drive, 20th Floor, LATHAM & WATKINS LLP, Costa Mesa, CA 92626, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 15, 2024

Serial Number98452032

Registration No.0

Status DateJan 23, 2025

Mark TypeStandard characters

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 01, 2023

First use in commerce: Jul 01, 2023

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jul 01, 2023

First use in commerce: Jul 01, 2023

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

10 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jan 23, 2025

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jan 23, 2025

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

NON-FINAL ACTION WRITTEN

Oct 07, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 07, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 07, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 25, 2024

ASSIGNED TO EXAMINER

TEAS VOLUNTARY AMENDMENT RECEIVED

Sep 12, 2024

TEAS VOLUNTARY AMENDMENT RECEIVED

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

Sep 12, 2024

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 09, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 17, 2024

NEW APPLICATION ENTERED

ONCOLYTIC IMMUNOTHERAPY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by CG Oncology, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Perry J. Viscounty

Industries

USPTO Deadlines

Compare

Resources

Company